Biocon Biologics and Janssen Sign License Pact For Biosimilar Product

Biocon Biologics said it has signed a settlement and licence pact with drug firm Janssen to market its biosimilar item to deal with different sicknesses like psoriasis, Crohn's illness and ulcerative colitis, in the US. The organization's item...

Stryker Expands Medical Device Testing Lab in India for Global Innovation

Stryker, a global leader in medical technologies, officially expanded its prototype and testing facility in India today, marking significant growth of its RandD footprint.

Veradigm Acquires ScienceIO for Healthcare AI Advancement

Veradigm, Inc., a leading provider of healthcare data and technology products and solutions, announced that it has signed a definitive agreement to acquire ScienceIO, a leading AI platform and foundation model provider for healthcare.

Viatris & Idorsia Global R&D Collaboration

Viatris Inc., a global healthcare company, and Idorsia Ltd announced they have entered into agreements for a significant worldwide research and development collaboration under which Viatris will receive exclusive worldwide development

Amneal's European Licensing Deal for IPX203 with Zambon Biotech

Bridgewater's Amneal Pharmaceuticals, a global pharmaceutical company, announced that it has signed an exclusive license agreement for IPX203 in the European Union, United Kingdom and Switzerland with Italy's Zambon Biotech SA, part of the Zambon

PulseSight's Minimally-Invasive Gene Therapy for Retinal Diseases

PulseSight Therapeutics SAS, an ophthalmology biotech company developing disruptive non-viral gene therapies with minimally-invasive delivery technology, launches with seed finance from Pureos Bioventures and ND Capital.

© 2024 India Pharma Outlook. All Rights Reserved.